1. Repository of OAI
Ελληνικά   English  

Browsing by Author Briasoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 11 to 30 of 126 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Cancer of Unknown Primary OriginBriasoulis, E.; Pavlidis, N.24-Nov-2015-
Cancer of unknown primary site: missing primary or missing biology?Pentheroudakis, G.; Briasoulis, E.; Pavlidis, N.24-Nov-2015-
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPavlidis, N.; Briasoulis, E.; Pentheroudakis, G.24-Nov-2015-
Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-upBriasoulis, E.; Pavlidis, N.; Felip, E.24-Nov-2015-
Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-upBriasoulis, E.; Pavlidis, N.24-Nov-2015-
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015-
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015-
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group StudyBriasoulis, E.; Kalofonos, H.; Bafaloukos, D.; Samantas, E.; Fountzilas, G.; Xiros, N.; Skarlos, D.; Christodoulou, C.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survivalZagorianakou, N.; Stefanou, D.; Makrydimas, G.; Zagorianakou, P.; Briasoulis, E.; Karavasilis, B.; Agnantis, N. J.24-Nov-2015-
CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literatureBriasoulis, E.; Kamposioras, K.; Tzovaras, V.; Pafitanis, G.; Kostoula, A.; Mavridis, A.; Pavlidis, N.24-Nov-2015-
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?Pentheroudakis, G.; Briasoulis, E.; Karavassilis, V.; Fountzilas, G.; Xeros, N.; Samelis, G.; Samantas, E.; Pavlidis, N.24-Nov-2015-
Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor supportBriasoulis, E.; Froudarakis, M.; Milionis, H. J.; Peponis, I.; Constantopoulos, S.; Pavlidis, N.24-Nov-2015-
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancerPallis, A. G.; Voutsina, A.; Kalikaki, A.; Souglakos, J.; Briasoulis, E.; Murray, S.; Koutsopoulos, A.; Tripaki, M.; Stathopoulos, E.; Mavroudis, D.; Georgoulias, V.24-Nov-2015-
Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma casesGogou, P.; Pakos, E.; Batistatou, A.; Panelos, I.; Briasoulis, E.; Stefanou, D.; Apostolikas, N.; Tsekeris, P.24-Nov-2015-
Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinomaKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Pavlidis, N.24-Nov-2015-
Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumorsZagorianakou, N.; Stefanou, D.; Makrydimas, G.; Zagorianakou, P.; Briasoulis, E.; Karavasilis, V.; Pavlidis, N.; Agnantis, N. J.24-Nov-2015-
Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancerIoachim, E.; Tsanou, E.; Briasoulis, E.; Batsis, C.; Karavasilis, V.; Charchanti, A.; Pavlidis, N.; Agnantis, N. J.24-Nov-2015-
Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix componentsTsanou, E.; Ioachim, E.; Briasoulis, E.; Charchanti, A.; Damala, K.; Karavasilis, V.; Pavlidis, N.; Agnantis, N. J.24-Nov-2015-
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupPectasides, D.; Samantas, E.; Fountzilas, G.; Briasoulis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.; Kalofonos, H. P.; Economopoulos, T.; Syrigos, K.24-Nov-2015-
Combination chemotherapy with cisplatin-vinblastine in malignant mesotheliomaTsavaris, N.; Mylonakis, N.; Karvounis, N.; Bacoyiannis, C.; Briasoulis, E.; Skarlos, D.; Pavlidis, N.; Stamatelos, G.; Kosmidis, P.24-Nov-2015-
Showing results 11 to 30 of 126 < previous   next >